Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1186/s12879-019-4197-7.pdf
Reference16 articles.
1. WHO Global Tuberculosis Report [ http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1 ].
2. Pontali E, Sotgiu G, D'Ambrosio L, Centis R, Migliori GB. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence. Eur Respir J. 2016;47:394–402.
3. FDA Bedaquiline accelerated approval letter [ https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/204384orig1s000ltr.pdf ].
4. Diacon A, Pym A, Grobusch M. The diarylquinoline TMC207 for multridrug-resistant tuberculosis. New Engl J Med. 2009;371:2397–405.
5. Diacon A, Pym A, Grobusch M. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. New Engl J Med. 2014;371:723–32.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New synergistic benzoquinone scaffolds as inhibitors of mycobacterial cytochrome bc1 complex to treat multi-drug resistant tuberculosis;European Journal of Medicinal Chemistry;2024-06
2. Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis;Antimicrobial Agents and Chemotherapy;2024-05
3. Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries;Frontiers in Medicine;2024-04-17
4. Bedaquiline and delamanid treatment outcomes among patients with drug-resistant tuberculosis: a systematic review and meta-analysis;Minerva Respiratory Medicine;2024-03
5. Bedaquiline’s Safety Profile Monitoring in India: Considerations for Future - A Systematic Review;Current Drug Safety;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3